Stephanie Roberson
Impact in
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 10%
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Cancer Mechanisms and Therapy 4
- Lymphoma Diagnosis and Treatment 2
-
- Cutaneous lymphoproliferative disorders research 2
- Co-authors
- Mark C. GenoveseIlaria BiaginiJ Sloan-LancasterFilip Van den BoschP. F. J. RyanJohn PolzerJohn R. StilleAmy Flynt
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)Lung Cancer (1 paper)Targeted Oncology (1 paper)
- Partner nations
- United StatesBelgiumMexico
In The Last Decade
Stephanie Roberson
10 papers receiving 617 citations
Peers
Comparison fields: 5 of 60
- Immunology 394
- Oncology 263
- Hematology 93
- Rheumatology 118
- Dermatology 61
Countries citing papers authored by Stephanie Roberson
This map shows the geographic impact of Stephanie Roberson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Roberson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Roberson more than expected).
Fields of papers citing papers by Stephanie Roberson
This network shows the impact of papers produced by Stephanie Roberson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Roberson. The network helps show where Stephanie Roberson may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephanie Roberson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 35 | |
| 2 | 2017 | 55 | |
| 3 | 2016 | 54 | |
| 4 | 2015 | 3 | |
| 5 | 2015 | 1 | |
| 6 | 2015 | 7 | |
| 7 | 2014 | 91 | |
| 8 | 2013 | 2 | |
| 9 | 2010 | 375 | |
| 10 | 2009 | 3 |
About Stephanie Roberson
Stephanie Roberson is a scholar working on Pathology and Forensic Medicine, Dermatology, Oncology, Immunology and Genetics, having authored 10 papers that have together received 626 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (5 papers), Cancer Mechanisms and Therapy (4 papers), Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (2 papers), Peptidase Inhibition and Analysis (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Immunology (394 citations), Oncology (263 citations), Hematology (93 citations), Rheumatology (118 citations) and Dermatology (61 citations). Stephanie Roberson has collaborated with scholars based in United States, Belgium and Mexico. Frequent co-authors include Mark C. Genovese, Ilaria Biagini, J Sloan-Lancaster, Filip Van den Bosch, P. F. J. Ryan, John Polzer, John R. Stille, Amy Flynt, Oday Hamid and Eyas Raddad. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Investigational New Drugs, Lung Cancer and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.